Every year on September 15th we join the myotonic dystrophy community in recognizing International Myotonic Dystrophy Day.
Dyne’s approach has great potential to address the underlying cause of many different neuromuscular diseases, and to develop transformative therapies that uniquely draw from the experience of people living with those diseases. I’m delighted to be part of the team furthering that important mission.